Shaan Patel

Shaan Patel

Auto-generated profile, based on publicly available information

Shaan Patel


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2021 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
JGJonah M. Graves
Jonah M. Graves
JVJulian A. Vallejo
Julian A. Vallejo
CHChelsea S. Hamill
Chelsea S. Hamill
DWDerek Wang
Derek Wang
RARohan Ahuja
Rohan Ahuja
MWMichael J. Wacker
Michael J. Wacker
Here we provide direct evidence that fibroblast growth factor 23 (FGF23), a phosphaturic hormone elevated in chronic kidney disease, is proarrhythmic. FGF23 acutely triggered ventricular arrhythmias and prolonged corrected QT interval (QTc) in isolated mouse hearts and in vivo. FGF23 also increased Ca2+ levels in ventricular muscle tissue. Blockade of the FGF receptor 4 signaling pathway using a monoclonal antibody ameliorated ventricular arrhythmias, QTc prolongation, and elevated ventricular Ca2+ induced by FGF23, and may represent a potential therapeutic target in chronic kidney disease.

26 May 2022 in International Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ZAZaki Al-Yafeai
Zaki Al-Yafeai
ACAlexander Carvajal-González
Alexander Carvajal-González
HAHamzah Abduljabar
Hamzah Abduljabar
MAMuhammed Arvas
Muhammed Arvas
SPShaan Patel
Shaan Patel
NPNeev Patel
Neev Patel
• Novel MS therapeutics have been recently approved by the FDA; however, the cardiovascular profile of these novel agents is poorly characterized. • CD20 and CD25 inhibitors are associated with a higher risk of AF, CAD and heart failure. • S1PR modulators are associated with significant bradycardia and AV block.

11 July 2021 in Journal of Perioperative Practice
Verified
Journal Article
Open access
PDF file
AZAndrew Zhou
Andrew Zhou
MGMilind Girish
Milind Girish
ATAzeem Thahir
Azeem Thahir
JLJiang An Lim
Jiang An Lim
CTCaitlyn Tran
Caitlyn Tran
MKMatija Krkovic
Matija Krkovic
Hydrogen peroxide has become more commonly used in hip arthroplasties due to high risk of periprosthetic infections. Its purported roles include irrigation, haemostasis, reduction of aseptic loosening and attachment of antibiotics. However, current literature does not provide conclusive evidence on the efficacy of hydrogen peroxide in preventing aseptic loosening, with some controversy around whether it in fact contributes to aseptic loosening. The complications of hydrogen peroxide across medicine are well distinguished; however, the risks within orthopaedic surgery and hip arthroplasties are not well known. Beyond cytotoxicity, the most dangerous reported risk associated with hydrogen peroxide in hip arthroplasties was an oxygen embolism in an unvented femoral canal and acrylic bone cement, consequentially leading to cardiac arrest. However, it may be inappropriate to solely attribute the oxygen embolism to the use of hydrogen peroxide and thus if used appropriately, hydrogen peroxide may have a justifiable role in hip arthroplasty surgery. In this narrative review, we present the current uses of hydrogen peroxide while evaluating its associated risks. We have summarised the key indications and aggregated recommendations to provide guidelines for the use of hydrogen peroxide in hip arthroplasty.

16 December 2025 in British Journal Of Neurosurgery
Verified
Journal Article
Open access
SNShiva A. Nischal
Shiva A. Nischal
SPShaan Patel
Shaan Patel
JYJason Yuen
Jason Yuen
AMAlex Mortimer
Alex Mortimer
NPNikunj K. Patel
Nikunj K. Patel
Cerebral blood flow (CBF) is under homeostatic control via cerebral autoregulation, maintaining a constant blood supply to brain parenchyma by integrating myogenic, metabolic, and neurogenic inputs across the neurovascular unit to stabilise perfusion despite physiological variations in cerebral perfusion pressure. While the mechanisms that underpin the control of CBF have been extensively investigated, this narrative review aims to holistically synthesise key findings for clinicians and researchers across healthy and diseased states. We first summarise autoregulatory inputs, cellular effectors, and typical stimuli/responses (with practical caveats including non-linearity, frequency dependence, and pressure-passivity). We then discuss monitoring approaches for assessing CBF and contrast cross-sectional techniques with portable bedside modalities, highlighting what each primarily measures (perfusion, velocity, oxygenation proxy, or flow index), their typical applications, and key constraints (radiation exposure, invasiveness, operator dependence, penetration depth, quantification). For historical context, we briefly note invasive monitors that remain selectively indispensable within multimodal neurocritical care. Looking forward, we outline emerging directions that prioritise non- and minimally-invasive solutions, including photoacoustic imaging, functional ultrasound, diffuse optical methods, speckle-based optics, and machine learning-enhanced post-processing, alongside hybrid multimodal integration. Collectively, these developments aim to improve accuracy, repeatability, and scalability of CBF monitoring and to support individualised decision-making across the clinical neurosciences.

13 January 2026 in Journal of Clinical Neuroscience
Verified
Journal Article
Open access
SPShaan Patel
Shaan Patel
SNShiva A. Nischal
Shiva A. Nischal
ASAyush Sinha
Ayush Sinha
KKKush M. Kale
Kush M. Kale
PPPious D. Patel
Pious D. Patel
SPSrinivas K. Prasad
Srinivas K. Prasad
External ventricular drains (EVDs) are fundamental to neurocritical care, yet substantial procedural heterogeneity persists, particularly regarding bolt-mounted versus tunnelled catheter fixation. The relative safety and effectiveness of these approaches remain unclear, with conflicting data from observational studies and a lack of trial-level evidence. To compare bolt-mounted and tunnelled EVDs across accuracy, reoperation, and key safety outcomes using systematic review, meta-analysis, and trial-sequential analysis. Following PRISMA guidelines, PubMed, Embase, and CENTRAL databases were searched (November 2025) for randomised or observational studies comparing bolt-mounted with tunnelled EVDs in adults. Two reviewers independently screened studies, extracted data, and assessed risk of bias. Primary outcomes were optimal catheter placement (Kakarla Grade I) and reoperation for EVD-related complications. Secondary outcomes included iatrogenic intracranial haemorrhage (ICH), cerebrospinal fluid (CSF) infection, CSF leak, catheter obstruction or malfunction, accidental discontinuation, and drainage duration. Random-effects meta-analyses were conducted using restricted maximum likelihood estimation. Heterogeneity was quantified, and certainty of evidence was assessed using GRADE. Trial-sequential analysis was performed for reoperation to determine whether available data met required information size thresholds. Ten studies encompassing 2008 patients (800 bolt-mounted, 1208 tunnelled) were included. Bolt-mounted EVDs demonstrated significantly higher optimal catheter accuracy (RR 1.27; 95% CI: 1.06-1.51; P < 0.01; I2 = 29.6 %). Reoperation was numerically lower with bolt-mounted systems (RR 0.51; 95% CI: 0.22-1.36; P = 0.19; I2 = 85 %), although trial-sequential analysis showed the cumulative Z-curve crossed the monitoring boundary without reaching the required information size, indicating insufficient evidence for definitive inference. Bolt-mounted EVDs were associated with lower CSF leak risk (RR 0.13; 95% CI: 0.04-0.47; P < 0.01) and reduced catheter obstruction (RR 0.46; 95% CI: 0.25-0.83; P < 0.05). No significant differences were observed in iatrogenic ICH (RR 1.23; 95% CI: 0.54-2.81; P = 0.62), CSF infection (RR 0.88; 95% CI: 0.71-1.09; P = 0.23), accidental discontinuation (RR 0.41; 95% CI: 0.11-1.59; P = 0.20), or drainage duration (MD 0.56 days; 95% CI = -1.02-2.13; P = 0.49). Bolt-mounted EVDs were associated with higher catheter accuracy, reduced CSF leak, and improved mechanical reliability without increased infection or haemorrhage. Although reoperation may be lower with bolt-mounted systems, current evidence remains underpowered for firm conclusions. These findings challenge historical assumptions regarding tunnelled catheters and may inform context-specific device selection in contemporary neurocritical care.

19 February 2026 in Journal of Clinical Neuroscience
Verified
Journal Article
Open access
ATAshviniy Thamilmaran
Ashviniy Thamilmaran
SNShiva A. Nischal
Shiva A. Nischal
SPShaan Patel
Shaan Patel
HPHoney Panchal
Honey Panchal
MMMary Murphy
Mary Murphy
Autologous bone flap preservation following decompressive craniectomy (DC) is routinely performed using either subcutaneous or cryogenic preservation. Despite widespread use, comparative effectiveness data remains conflicting, and the biological relevance of these preservation strategies incompletely defined. To compare clinical outcomes associated with subcutaneous versus cryogenic preservation of autologous bone flaps following DC using systematic review and meta-analysis, stratified by study design. PubMed, Embase, MEDLINE, and Cochrane Library were searched in accordance with PRISMA guidelines to identify randomised and observational studies comparing subcutaneous and cryogenic preservation in adults undergoing cranioplasty post-DC. Primary outcomes were surgical site infection (SSI), revision surgery, and bone flap resorption. Secondary outcomes included intracranial haematoma, length of hospital stay, and timing of cranioplasty. Random-effects meta-analyses were performed, with predefined stratification by randomised versus non-randomised study design. Risk of bias was assessed using RoB 2 and ROBINS-I. Certainty of evidence was evaluated using GRADE. A cost analysis from the UK NHS perspective was performed using revision surgery rates derived from randomised data. Seven studies encompassing 811 patients (337 subcutaneous; 474 cryogenic) were included. SSI occurred in 8.6% of subcutaneous and 11.6% of cryogenic patients, with no significant difference in pooled analysis (RR 0.55, 95% CI 0.22-1.34; P = 0.19). Stratified analysis showed a significantly lower SSI risk with subcutaneous preservation in randomised controlled trials (RCTs). Clinical bone flap resorption occurred in 14.7% of subcutaneous and 15.6% of cryogenic patients (RR 0.98, 95% CI 0.70-1.38; P = 0.91). Radiological bone flap resorption was associated with a non-significant trend favouring subcutaneous preservation (mean difference -0.38 mm, 95% CI -0.80-0.04; P = 0.08). Revision surgery occurred in 11.2% of subcutaneous and 11.8% of cryogenic cases (RR 0.92, 95% CI 0.33-2.50; P = 0.86), but was significantly lower with subcutaneous preservation in RCTs. Mortality and secondary outcomes did not differ between strategies. Observational studies were judged to have serious risk of bias, with moderate certainty for RCT-derived outcomes. Subcutaneous preservation was associated with an absolute reduction in revision surgery, corresponding to a number needed to treat of 11. Subcutaneous and cryogenic bone flap preservation strategies yielded comparable outcomes in routine clinical practice. However, randomised evidence suggests a potential clinical advantage of subcutaneous preservation for infection-related outcomes and revision surgery, which is biologically plausible but not directly measured in the included studies, supporting the need for further adequately powered, biologically informed randomised trials.